Request Sample

Global Bipolar Disorder Treatment Market

Dec. 1, 2019

Global Bipolar Disorder Treatment Market, By Drug Type (Antipsychotic, Antidepressant, Anticonvulsants, Antianxiety, Mood Stabilizers, Others), By Bipolar Disorder Type (Bipolar I and Bipolar II), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, etail Pharmacies and Online Pharmacies), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR289      
Pages :200 Pages
Format :   PPT Format   PDF Format

The global bipolar disorder treatment market was valued at US$ xx million in the year 2018. This market is estimated to be valued at US$ xx million in the year 2019 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of 5.5% during the forecast period (2020-2025). The growth of bipolar disorder treatment market is enhanced by the growing cases of bipolar disorder and rich pipeline drugs under clinical trial by many pharmaceutical companies. Additionally, technological advancement in drug development and increased incidence of neurological disorders are some of the impacting factors for the demand of drugs.

Table 1. Global Bipolar Disorder Treatment Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Drug Type)

Antipsychotic, Antidepressant, Anticonvulsants, Antianxiety, Mood Stabilizers, Others

Market Segmentation (By Bipolar Disorder Type)

Bipolar I and Bipolar II

Market Segmentation (By Route of Administration)

Oral, Parenteral, Others

Market Segmentation (By Distribution Channel)

Hospital Pharmacies, etail Pharmacies and Online Pharmacies

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East & Africa,

Key Players Coverage

Zydus Cadila, Mylan N.V., Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, AbbVie Inc, Allergan, Mallinckrodt plc, Sun Pharmaceutical Industries Ltd., Novartis AG, Endo Pharmaceuticals plc, Amneal Pharmaceutical Inc, Alkermes, Avet Pharmaceuticals Inc., Lannett, Aurobindo Pharma, Wockhardt, Currax Pharmaceuticals LLC, among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

 

Market Dynamics

Increasing prevalence of bipolar disorder, and the government support for generating awareness about the bipolar disorder are expected to drive the market growth. For instance, International Bipolar Foundation (IBPF) in collaboration with the Asian Network of Bipolar Disorder (ANBD) and the International Society for Bipolar Disorders (ISBD) celebrate March 30th as World Bipolar Day (WBD) to increase awareness about bipolar conditions and to eliminate social stigma related to it. Additionally, technological advancements like smarthphone apps- eMoods and Moodlytics, facilitate accurate detection of a patient’s mood and mental state are few of the factors driving the growth of this market. Additionally,  scientific organizations and institutions still play an important role in carrying out clinical trials and design new medications and bipolar disorder therapies. For instance, the Salk Institute for Biological Studies and the John Hopkins University of Medicine, initiated an effort in 2016 to create an experimental research and techniques for screening of bipolar disorder and schizophrenia. Nevertheless, stringent regulations regarding the usage of drugs and side effects coupled with it, may hinder the bipolar disorder treatment market growth.

Figure 1. Bipolar Disoirder Treatment Market Scenario Forecast (Likely, Conservative, and Optimistic Scenario), 2019 and 2025 (US$ Mn)

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

 

Owing to the rise in the number of the FDA approved medications and increased variety of therapeutic services for patients with bipolar disorders is expected to dominate the North American bipolar disorder treatment market. For instance, olanzapine (Zyprexa) when used with fluoxetine (Prozac) (which also comes as a combination pill called Symbyax), and lurasidone (Latuda) used alone or with lithium are some of the FDA approved medications for bipolar disorder. Additionally, government initiatives for creating awareness regarding bipolar disorder is expected to foster the market growth. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) and Center for Mental Health Services (CMHS) have increased their funding for diagnosis and rehabilitation in mental wellbeing.

Asia-Pacific is expected to witness relatively high CAGR than other regions over the forecast period, which can be associated with high prevalence of mental disorders in this region. According to the WHO data, India and China rank among the countries most affected by mental disorders such as anxieties, schizophrenia and bipolar disorder.

Figure 2. Regional Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in global bipolar disorder  treatment market include Zydus Cadila, Mylan N.V., Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, AbbVie Inc, Allergan, Mallinckrodt plc, Sun Pharmaceutical Industries Ltd., Novartis AG, Endo Pharmaceuticals plc, Amneal Pharmaceutical Inc, Avet Pharmaceuticals Inc., Lannett, Aurobindo Pharma, Wockhardt, Alkermes, Currax Pharmaceuticals LLC, among others.

Key players in the market are focused on new drug launches, expansions and acquisitions. For instance, in January 2020, the FDA approved, Alkermes’s ALKS 3831 (olanzapine/samidorphan), a drug used for treatment of schizophrenia and bipolar disorder. 

Figure 3. Market Share of Key Players, 2019

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

By Drug Type

  • Antipsychotic
  • Antidepressant
  • Anticonvulsants
  • Antianxiety
  • Mood Stabilizers
  • Others

By Bipolar Disorder Type

  • Bipolar I
  • Bipolar II

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global bipolar disorder treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global bipolar disorder treatment market?
  • What key factors are expected to increase the demand for the global bipolar disorder treatment market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global bipolar disorder treatment market?
  • What is the total market value (US$ Mn) generated in the global bipolar disorder treatment market by drug type in 2019 and what are the forecasts by 2025?
  • Which bipolar disorder type is expected to dominate the global bipolar disorder treatment market in the coming years?
  • Which route of administration is expected to foster the bipolar disorder treatment market growth?
  • Which distribution channel contributes the highest CAGR (%) in the bipolar disorder treatment market?
  • What was the total revenue generated by the global bipolar disorder treatment market across different regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global bipolar disorder treatment market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the global bipolar disorder treatment market?
  • What new products are going to be approved or launched in the coming years which may have a huge impact on the market?
  • What insights are derived through the analysis of key players on the following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Oncology Precision Medicine Market

Global Oncology Precision Medicine Market, By Ecosystem (Applied Sciences (Genomics, Pharmacogenomics and Other Applied Sciences), Precision Diagnostics (Molecular Diagnostics …

Read More

Global Small Molecule Drug Discovery Market

Global Small Molecule Drug Discovery Market, By Therapeutic Type (Central Nervous System (CNS), Cardiovascular, Oncology, Metabolic Disorders, Gastrointestinal, Orthopedics, …

Read More

Global Diabetes Drugs Market

Global Diabetes Drugs Market, By Diabetes Type (Type-1 & Type-2), By Drug (Oral Anti-Diabetic Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine …

Read More

Global Bipolar Disorder Treatment Market

Global Bipolar Disorder Treatment Market, By Drug Type (Antipsychotic, Antidepressant, Anticonvulsants, Antianxiety, Mood Stabilizers, Others), By Bipolar Disorder Type …

Read More

Global Cytotoxic Drugs Contract Manufacturing Market

Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type (Oral, Intravenous), By Form (Liquid, Solid), By Production Scale (Laboratory …

Read More

India Acetazolamide Market

India Acetazolamide Market, By Formulation (Tablets, Capsules, and Injection), By Application (Glaucoma, Epilepsy, Drug-induced Edema, Altitude …

Read More

India Diclofenac Market

India Diclofenac Market, By Indication (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid Arthritis, Migraine, Pain, and Others), By Route of Administration …

Read More

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market, By Drug Class (Contraceptives & Antiandrogens (Provera, Yasminell, Clomid, Aldactone, Diane 35, …

Read More
Validation error occured. Please enter the fields and submit it again.